Cerebras (CBRS) Stock Down 30% Since IPO as Wall Street Analysts Issue Strong Buy Signals

Key Takeaways

• Cerebras (CBRS) shares have retreated significantly from their post-IPO peak of $300, hovering near $211 in Monday’s early premarket session
• Six Wall Street firms launched coverage Monday with Buy or Outperform recommendations and price objectives spanning $250 to $300
• The AI chipmaker boasts a $24.6 billion order backlog, primarily driven by a substantial agreement with OpenAI and an additional contract with AWS
• Cerebras’ flagship Wafer-Scale Engine represents the world’s largest commercial chip, specifically designed for rapid AI inference operations
• Trailing twelve-month revenue reached $510 million with 76% year-over-year expansion, though shares command a premium 225x earnings valuation

---

The market debut of Cerebras Systems was nothing short of spectacular. Following last month’s initial public offering, the artificial intelligence semiconductor company watched its shares surge beyond $300 almost instantly. That euphoria proved short-lived.

Cerebras Systems Inc., CBRS

Shares of CBRS changed hands around $211.80 during Monday’s premarket hours, reflecting a 5.4% intraday gain while remaining substantially below those initial peaks. The stock absorbed a 6.7% decline the prior week amid a broader selloff across semiconductor equities.

Enter Wall Street’s research analysts — and their timing couldn’t be more deliberate. A coordinated series of coverage launches suggests the Street believes current pricing presents opportunity.

Mizuho analyst Vijay Rakesh broke cover first, assigning an Outperform recommendation alongside a $300 price objective. Wedbush’s Matt Bryson matched that enthusiasm with a Buy rating and $270 target. Barclays established an overweight stance at $280. Both UBS and Rosenblatt arrived at $300 targets. Morgan Stanley took the most measured approach, initiating overweight coverage with a $250 price goal.

That’s a unanimous chorus of optimism from major investment banks in a single trading session.

Cerebras’ Technological Edge

The investment thesis centers on the company’s unique silicon approach. Cerebras manufactures the Wafer-Scale Engine — recognized as the largest commercially available chip on the planet. This semiconductor was purpose-built for AI inference, the computational stage where trained models generate real-world outputs.

Where Nvidia’s strategy relies on connecting thousands of discrete GPUs through intricate networking infrastructure, Cerebras consolidates everything onto a single wafer-sized chip. This design eliminates substantial computational overhead and accelerates token generation speeds.

Massive Backlog Meets Concentration Questions

Cerebras disclosed a revenue pipeline totaling $24.6 billion at the close of 2025. That figure commands attention. The complication: a substantial portion originates from a single customer relationship with OpenAI.

This customer concentration has generated investor skepticism. Yet the company secured an additional agreement with Amazon Web Services, introducing a second blue-chip customer that provides some counterbalance to concentration concerns.

His $270 valuation derives from applying a 40x multiple to his 2028 earnings projection, adjusted for net cash holdings.

Trailing twelve-month sales totaled $510 million, representing 76% growth compared to the prior year. The equity trades at a 225x earnings multiple, a level InvestingPro identified as exceeding fair value estimates.

By mid-morning Monday, CBRS shares traded approximately 14% higher at the premarket price near $211, based on refreshed market data.

The post Cerebras (CBRS) Stock Down 30% Since IPO as Wall Street Analysts Issue Strong Buy Signals appeared first on Blockonomi.